The global contrast media market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. An increase in the prevalence of long-term diseases and complex comorbidities has led to a rise in the number of diagnostic imaging tests.
Contrast media is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radio density in a target tissue or structure. Contrast agents are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. Several types of contrast media are in use in medical imaging and they can roughly be classified based on the imaging modalities where they are used. Most common contrast agents work based on X-ray attenuation and magnetic resonance signal enhancement.
This Contrast Media market report covers the latest trends, trade rules, import / export analysis, production analysis, value chain optimization, market share, impact on regional and domestic market players, new sales pockets, market rule change opportunity analysis, strategic outlook analysis. Market growth, market size, category growth, applications and niches, product approvals, product launches, geographic expansion, market innovation.
On the basis of Product Type:
On the basis of the end Applications:
Key Player Mentioned:
General Electric Company
Bracco Diagnostic, Inc.
Nano Therapeutics Pvt. Ltd.
Lantheus Medical Imaging, Inc.
Regional Segment Analysis:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
According to the WHO, as of July 19, 2020, nearly 3,544,143 confirmed cases of COVID-19 and approximately 137,674 related deaths were reported in the U.S., making it the country with the highest number of confirmed cases across the globe. On the other hand, China, the epicenter of the pandemic, reported nearly 85,937 confirmed cases and approximately 4,653 deaths. The use of X-ray and chest CT imaging for the detection of COVID-19-related lesions in the lungs for disease management is anticipated to drive the market.
Access Press Release @ https://www.grandviewresearch.com/press-release/global-contrast-media-contrast-agents-market
The outbreak of the COVID-19 pandemic has significantly increased the demand for antiviral medicines globally. The treatment of novel coronavirus has increased the demand for broad-spectrum Glucose to manage the disease. Remdesivir, favipiravir, oseltamivir, and other combination medicines are highly prescribed for the treatment of COVID-19. Moreover, governments are increasing funding to pharmaceutical companies to develop novel therapeutics against COVID-19. For instance, in June 2021, the U.S. government has announced an investment of more than USD 3 billion to fasten the discovery, development, and manufacturing of antiviral medicines for COVID-19 treatment. The rising incidence of disease coupled with increasing R&D will increase the demand for Glucose in the next 2 to 3 years.
KEY aspects covered in the report include:
- The market size and industry growth rate of the global and regional market across various segments
- The region or the sub-segment that is expected to drive the contrast media market in the forecast period 2021-2028
- Key companies operating in the global contrast media market and their market share
- The Factors that are estimated to drive the contrast media Market growth
- Key opportunities in the contrast media market
- Key technological advancements and market trends that shape the market
The study objectives of this report are:
- To research global status, future forecasts, growth opportunities, key markets and key players.
- To present the market development in us, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and methods.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.